Medical device maker Beyond Air falls after Q3 revenue misses
** Medical device maker Beyond Air's XAIR.O shares fall
11.2% to $1.91 premarket
** Reports Q3 revenue of $391 mln vs est $446 mln - LSEG
** Posts Q3 loss of $0.50/shr vs est of loss of $0.53/shr
** Quarterly R&D expenses rise to $6.8 mln vs $5 mln a year
earlier
** Company reiterates FY 2025 revenue forecast of $12 mln to
$16 mln
** As of Monday's close, stock down ~65% in past 12 months
(Reporting by Khushi Mandowara in Bengaluru)
((Khushi.Mandowara@thomsonreuters.com))
Recent news on Beyond Air
See all newsBrief: Beyond Air Enters Definitive Agreement To Sell Its NeuroNOS Stake To UNIVO Pharmaceutical Industries In Exchange For Equity And Milestone Payments
Beyond Air Inc reports results for the quarter ended June 30 - Earnings Summary
Beyond Air Q1 net loss slightly widens, reaffirms 2026 outlook
Beyond Air Inc expected to post a loss of $10.80 a share - Earnings Preview
NASDAQ RESUMED AT 04:00 AM